12 December 2002 10:31 [Source: ICIS news]
LONDON (CNI)--Swiss pharmaceuticals group Roche confirmed on Thursday that Mark Altwegg, executive committee member and head of the vitamins and fine chemicals division, is to retire from operational duties in spring (Q1/2) next year.
His retirement will coincide with the transfer of the vitamins and fine chemicals business to DSM, the Dutch chemicals, performance materials and life sciences group. DSM agreed last September to buy the business for Euro2.25bn (about $2.27bn).
Altwegg, who joined Roche 34 years ago and became head of the vitamins and fine chemicals in 1999, will remain a director of F Hoffmann-La Roche. He will also become chairman on 9 May next year of Siegfried Holding, the Zofingen, Switzerland based manufacturer of active pharmaceutical ingredients and advanced intermediates.
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.
|ICIS news FREE TRIAL|
|Get access to breaking chemical news as it happens.|
|ICIS Global Petrochemical Index (IPEX)|
|ICIS Global Petrochemical Index (IPEX). Download the free tabular data and a chart of the historical index|